Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Lymphoma

Free Subscription Articles published in Leukemia Retrieve available abstracts of 58 articles: HTML format Text format

Single Articles

January 2012
1. BIKOS V , Darzentas N, Hadzidimitriou A, Davis Z, et al
   Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.
   Leukemia. 2012 Jan 6. doi: 10.1038/leu.2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. NAKAHATA S , Saito Y, Marutsuka K, Hidaka T, et al
   Clinical significance of CADM1/TSLC1/IgSF4 expression in adult T-cell leukemia/lymphoma.
   Leukemia. 2012 Jan 6. doi: 10.1038/leu.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
3. COCCO C , Di Carlo E, Zupo S, Canale S, et al
   Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo.
   Leukemia. 2011 Dec 23. doi: 10.1038/leu.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. SCHUETZ JM , Johnson NA, Morin RD, Scott DW, et al
   BCL2 mutations in diffuse large B-cell lymphoma.
   Leukemia. 2011 Dec 22. doi: 10.1038/leu.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. MERKEL O , Kenner L, Turner SD
   Anaplastic large cell lymphoma: the current state of play from a European prospective as presented at the second annual meeting of the European Research Initiative on ALCL, 27-28 June 2011.
   Leukemia. 2011;25:1795-6.
   PubMed     Text format     Related articles   
   
   
   
   
6. NOWAKOWSKI GS , LaPlant B, Habermann TM, Rivera CE, et al
   Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study.
   Leukemia. 2011;25:1877-81.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
7. RAO E , Jiang C, Ji M, Huang X, et al
   The miRNA-17 approximately 92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
   Leukemia. 2011 Nov 25. doi: 10.1038/leu.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. GUPTA M , Han JJ, Stenson M, Wellik L, et al
   Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy.
   Leukemia. 2011 Nov 25. doi: 10.1038/leu.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. MEYNET O , Beneteau M, Jacquin MA, Pradelli LA, et al
   Glycolysis inhibition targets Mcl-1 to restore sensitivity of lymphoma cells to ABT-737-induced apoptosis.
   Leukemia. 2011 Nov 11. doi: 10.1038/leu.2011.
   PubMed     Text format     Related articles   
   
   
   
   October 2011
10. MOORE CR , Liu Y, Shao C, Covey LR, et al
    Specific deletion of TRAF3 in B lymphocytes leads to B-lymphoma development in mice.
    Leukemia. 2011 Oct 28. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles   
    
    
    
    
11. ANSELL SM , Tang H, Kurtin PJ, Koenig PA, et al
    Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphoma.
    Leukemia. 2011 Oct 21. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. AME-THOMAS P , Le Priol J, Yssel H, Caron G, et al
    Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells.
    Leukemia. 2011 Oct 21. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. KELLNER C , Hallack D, Glorius P, Staudinger M, et al
    Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity.
    Leukemia. 2011 Oct 18. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles   
    
    
    
    September 2011
14. LAUNAY E , Pangault C, Bertrand P, Jardin F, et al
    High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis.
    Leukemia. 2011 Sep 23. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles   
    
    
    
    
15. FRUCHON S , Kheirallah S, Al Saati T, Ysebaert L, et al
    Involvement of the Syk-mTOR pathway in follicular lymphoma cell invasion and angiogenesis.
    Leukemia. 2011 Sep 16. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. DODERO A , Spina F, Narni F, Patriarca F, et al
    Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.
    Leukemia. 2011 Sep 9. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. BRAUN FC , Grabarczyk P, Mobs M, Braun FK, et al
    Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sezary syndrome.
    Leukemia. 2011;25:1494-501.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. XIANG H , Noonan EJ, Wang J, Duan H, et al
    The immunoglobulin heavy chain gene 3' enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells.
    Leukemia. 2011;25:1484-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
19. RAMAKRISHNAN V , Ansell S, Haug J, Grote D, et al
    MRK003, a gamma-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma.
    Leukemia. 2011 Aug 9. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. AMMERPOHL O , Haake A, Pellissery S, Giefing M, et al
    Array-based DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B cell-specific genes.
    Leukemia. 2011 Aug 5. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles   
    
    
    
    
21. DECKERT M , Engert A, Bruck W, Ferreri AJ, et al
    Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma.
    Leukemia. 2011 Aug 5. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. IQBAL J , Weisenburger DD, Chowdhury A, Tsai MY, et al
    Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.
    Leukemia. 2011;25:1377.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
23. MARTIN-PEREZ D , Vargiu P, Montes-Moreno S, Leon EA, et al
    Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma.
    Leukemia. 2011 Jul 26. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles   
    
    
    
    
24. EPRON G , Ame-Thomas P, Le Priol J, Pangault C, et al
    Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling.
    Leukemia. 2011 Jul 26. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. DEJEAN E , Renalier MH, Foisseau M, Agirre X, et al
    Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas.
    Leukemia. 2011 Jul 22. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. HALLDORSDOTTIR AM , Lundin A, Murray F, Mansouri L, et al
    Impact of TP53 mutation and 17p deletion in mantle cell lymphoma.
    Leukemia. 2011 Jul 1. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
27. LENZE D , Leoncini L, Hummel M, Volinia S, et al
    The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.
    Leukemia. 2011 Jun 24. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. QIN Z , Dai L, Bratoeva M, Slomiany MG, et al
    Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma.
    Leukemia. 2011 Jun 10. doi: 10.1038/leu.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. LEWIS TS , McCormick RS, Stone IJ, Emmerton K, et al
    Proapoptotic signaling activity of the anti-CD40 monoclonal antibody dacetuzumab circumvents multiple oncogenic transformation events and chemosensitizes NHL cells.
    Leukemia. 2011;25:1007-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
30. LIU C , Gao F, Li B, Mitchel RE, et al
    TLR4 knockout protects mice from radiation-induced thymic lymphoma by downregulation of IL6 and miR-21.
    Leukemia. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
31. WILCOX RA , Ristow K, Habermann TM, Inwards DJ, et al
    The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma.
    Leukemia. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. TAMAI H , Miyake K, Takatori M, Miyake N, et al
    Activated K-Ras protein accelerates human MLL/AF4-induced leukemo-lymphomogenicity in a transgenic mouse model.
    Leukemia. 2011;25:888-91.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
33. WATANABE A , Tagawa H, Yamashita J, Teshima K, et al
    The role of microRNA-150 as a tumor suppressor in malignant lymphoma.
    Leukemia. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. YAKIMCHUK K , Iravani M, Hasni MS, Rhonnstad P, et al
    Effect of ligand-activated estrogen receptor beta on lymphoma growth in vitro and in vivo.
    Leukemia. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
35. DRAKOS E , Singh RR, Rassidakis GZ, Schlette E, et al
    Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).
    Leukemia. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
36. VANDEWOESTYNE ML , Pede VC, Lambein KY, Dhaenens MF, et al
    Laser microdissection for the assessment of the clonal relationship between chronic lymphocytic leukemia/small lymphocytic lymphoma and proliferating B cells within lymph node pseudofollicles.
    Leukemia. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
37. TUVE S , Gayoso J, Scheid C, Radke J, et al
    Haploidentical bone marrow transplantation with post-grafting cyclophosphamide: multicenter experience with an alternative salvage strategy.
    Leukemia. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
38. HUANG Q , Snyder DS, Chu P, Gaal KK, et al
    PDGFRA rearrangement leading to hyper-eosinophilia, T-lymphoblastic lymphoma, myeloproliferative neoplasm and precursor B-cell acute lymphoblastic leukemia.
    Leukemia. 2011;25:371-5.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
39. KWIECINSKA A , Ottosson-Wadlund A, Ceder R, Grafstrom RC, et al
    HAX-1 expression in human B lymphoma.
    Leukemia. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
40. BELLONI E , Shing D, Tapinassi C, Viale A, et al
    In vivo expression of an aberrant MYB-GATA1 fusion induces leukemia in the presence of GATA1 reduced levels.
    Leukemia. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
41. HASEGAWA H , Yamada Y, Tsukasaki K, Mori N, et al
    LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway.
    Leukemia. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. RUMINY P , Etancelin P, Couronne L, Parmentier F, et al
    The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma.
    Leukemia. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. TAN SY , Ooi AS, Ang MK, Koh M, et al
    Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma.
    Leukemia. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
44. BODOR C , O'Riain C, Wrench D, Matthews J, et al
    EZH2 Y641 mutations in follicular lymphoma.
    Leukemia. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
45. LIN J , Lwin T, Zhao JJ, Tam W, et al
    Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas.
    Leukemia. 2011;25:145-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
46. DELGADO J , Canals C, Attal M, Thomson K, et al
    The role of in vivo T-cell depletion on reduced-intensity conditioning allogeneic stem cell transplantation from HLA-identical siblings in patients with follicular lymphoma.
    Leukemia. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
47. WITZIG TE , Reeder CB, Laplant BR, Gupta M, et al
    A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma.
    Leukemia. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. KOPP KL , Dabelsteen S, Krejsgaard T, Eriksen KW, et al
    COX-2 is a novel target in therapy of mycosis fungoides.
    Leukemia. 2010;24:2127-9.
    PubMed     Text format     Related articles   
    
    
    
    November 2010
49. ZHANG L , Jiang Y, Zheng Y, Zeng Y, et al
    Selective killing of Burkitt's lymphoma cells by mBAFF-targeted delivery of PinX1.
    Leukemia. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. IQBAL J , Weisenburger DD, Chowdhury A, Tsai MY, et al
    Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.
    Leukemia. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. JOSEPH-PIETRAS D , Gao Y, Zojer N, Ait-Tahar K, et al
    DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
    Leukemia. 2010;24:1951-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. COSTA ES , Pedreira CE, Barrena S, Lecrevisse Q, et al
    Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping.
    Leukemia. 2010;24:1927-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
53. BURKHARDT B , Oschlies I, Klapper W, Zimmermann M, et al
    Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols.
    Leukemia. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. PANGAULT C , Ame-Thomas P, Ruminy P, Rossille D, et al
    Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.
    Leukemia. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
55. THEPOT S , Zhou J, Perrot A, Robin M, et al
    The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation.
    Leukemia. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. DANIELS TR , Neacato II, Rodriguez JA, Pandha HS, et al
    Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells.
    Leukemia. 2010;24:1555-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
57. BHENDE PM , Park SI, Lim MS, Dittmer DP, et al
    The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma.
    Leukemia. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
58. SHIMIZU R , Kikuchi J, Wada T, Ozawa K, et al
    HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells.
    Leukemia. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: